Search

everythinglearnresearchcommunity

for

Search:↓

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Apremilast shows promise for several skin conditions but needs more research.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Cannabinoids may help some skin conditions but more research is needed.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Aging-related changes in hair follicle stem cells can be partially reversed with a specific treatment.

The document suggests that hair loss after stopping birth control may be similar to post-pregnancy hair loss and could recur with future pregnancies.